Lonza to manufacture Intellect Neurosciences drug; Scammers go after Internet drug buyers;

> India has put new price controls on nearly 350 drugs, up from the 74 that had limits. Story

> Drugmakers are now owed between $15.4 billion and $19.5 billion by European countries that have yet to pay their pharma bills. Story

> Intellect Neurosciences plans to have Lonza manufacture its new antibody-drug conjugate Conjumab-A. Item

> Indian API maker Cadila Pharmaceutical says one of its employees working with its pharmaceutical division has been arrested for embezzlement. Story

> While the diabetes drug metformin holds potential as a cheap and effective treatment against some cancers, drugmakers are reluctant to invest in research for a drug already off patent. Story

And Finally... The FDA is investigating reports that scammers are calling people who have purchased drugs from Internet pharmacies and threatening them if they don't pay fines. Story

Suggested Articles

Colorado is making a play for a Japanese CDMO in hopes it will invest about $100 million in an empty AstraZeneca plant in Boulder.

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.